Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Apyx Medical Revises 2025 Total Revenue Outlook From $47.6M - $49.5M To $47.6M - $49.0M, Est $48.462M

Author: Benzinga Newsdesk | March 13, 2025 06:08am

The Company continues to expect operating expenses of less than $40.0 million for the year ended December 31, 2025.

Posted In: APYX